This inventor holds 35 USPTO granted patents and 34 published patent applications, plus 16 CIPO patents and 23 EPO patents, primarily in Controlled Release Formulations. Top assignees: Camurus Ab, Camarus Ab, Camrus Ab. Active years: 2012-2026.
Location History:
- Lund, CH (2014)
- Lund, SE (2012 - 2024)
Company Filing History:
Years Active: 2012-2026
Areas of Expertise:
Title: Innovations in Pain Management: The Patents of Fredrik Tiberg
Introduction: Fredrik Tiberg, a noted inventor based in Lund, Sweden, is recognized for his significant contributions to the pharmaceutical industry, particularly in the field of pain management. With an extensive portfolio of 31 patents, Tiberg has been at the forefront of developing advanced opioid formulations aimed at improving patient outcomes in pain therapy.
Latest Patents: Among his most recent inventions are two notable patents focusing on opioid formulations. The first is a depot precursor formulation that features a controlled-release matrix and a minimum of 12% by weight of buprenorphine or its salts, aimed at enhancing pain management. This invention outlines methods of treatment that involve opioid maintenance and innovative related methods. The second patent introduced by Tiberg is an injectable buprenorphine formulation, which consists of a lipid-controlled release matrix containing at least 50% triacyl lipids and a minimum of 16% by weight of buprenorphine. This formulation not only focuses on pain treatment but also offers pathways for opioid maintenance therapy and the management of withdrawal symptoms associated with opioid and cocaine dependence.
Career Highlights: Fredrik Tiberg's career has been marked by his dedication to advancing medical science through innovation. He has made significant strides in the pharmaceutical field, particularly through his work at companies like Camurus AB. His passion for improving pain management therapies has been a driving force behind his inventive pursuits, leading to the development of several impactful formulations.
Collaborations: Throughout his career, Tiberg has collaborated with notable professionals in the field. Among his coworkers are Markus Johnsson and Fredrik Joabsson, who share a commitment to developing pharmaceutical innovations that address complex medical challenges.
Conclusion: Fredrik Tiberg's innovative work has made a lasting impact on the realm of pain management and opioid therapy. His patents demonstrate a commitment to enhancing treatment options for patients dealing with pain and dependence. As the landscape of pharmaceutical inventions continues to evolve, inventors like Tiberg play a crucial role in shaping the future of healthcare.